Since adiponectin has recently been shown to act as an endogenous anti-fibrotic mediator [49], we speculate that the decrease in adiponectin expression might have a prominent role in the SSc serum-induced acquisition of myofibroblastic features by ADSC. The gene discussed is ADIPOQ; the disease is systemic sclerosis.